Global Neurological Disorder Drugs Market Growth 2022-2028

Global Neurological Disorder Drugs Market Growth 2022-2028

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Neurological Disorder Drugs Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Neurological Disorder Drugs by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Neurological Disorder Drugs by Country/Region, 2017, 2022 & 2028
2.2 Neurological Disorder Drugs Segment by Type
2.2.1 Antipsychotic
2.2.2 Hypnotic & Sedative
2.2.3 Analgesics
2.2.4 Anticoagulants
2.2.5 Others
2.3 Neurological Disorder Drugs Sales by Type
2.3.1 Global Neurological Disorder Drugs Sales Market Share by Type (2017-2022)
2.3.2 Global Neurological Disorder Drugs Revenue and Market Share by Type (2017-2022)
2.3.3 Global Neurological Disorder Drugs Sale Price by Type (2017-2022)
2.4 Neurological Disorder Drugs Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.5 Neurological Disorder Drugs Sales by Application
2.5.1 Global Neurological Disorder Drugs Sale Market Share by Application (2017-2022)
2.5.2 Global Neurological Disorder Drugs Revenue and Market Share by Application (2017-2022)
2.5.3 Global Neurological Disorder Drugs Sale Price by Application (2017-2022)
3 Global Neurological Disorder Drugs by Company
3.1 Global Neurological Disorder Drugs Breakdown Data by Company
3.1.1 Global Neurological Disorder Drugs Annual Sales by Company (2020-2022)
3.1.2 Global Neurological Disorder Drugs Sales Market Share by Company (2020-2022)
3.2 Global Neurological Disorder Drugs Annual Revenue by Company (2020-2022)
3.2.1 Global Neurological Disorder Drugs Revenue by Company (2020-2022)
3.2.2 Global Neurological Disorder Drugs Revenue Market Share by Company (2020-2022)
3.3 Global Neurological Disorder Drugs Sale Price by Company
3.4 Key Manufacturers Neurological Disorder Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Neurological Disorder Drugs Product Location Distribution
3.4.2 Players Neurological Disorder Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Neurological Disorder Drugs by Geographic Region
4.1 World Historic Neurological Disorder Drugs Market Size by Geographic Region (2017-2022)
4.1.1 Global Neurological Disorder Drugs Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Neurological Disorder Drugs Annual Revenue by Geographic Region
4.2 World Historic Neurological Disorder Drugs Market Size by Country/Region (2017-2022)
4.2.1 Global Neurological Disorder Drugs Annual Sales by Country/Region (2017-2022)
4.2.2 Global Neurological Disorder Drugs Annual Revenue by Country/Region
4.3 Americas Neurological Disorder Drugs Sales Growth
4.4 APAC Neurological Disorder Drugs Sales Growth
4.5 Europe Neurological Disorder Drugs Sales Growth
4.6 Middle East & Africa Neurological Disorder Drugs Sales Growth
5 Americas
5.1 Americas Neurological Disorder Drugs Sales by Country
5.1.1 Americas Neurological Disorder Drugs Sales by Country (2017-2022)
5.1.2 Americas Neurological Disorder Drugs Revenue by Country (2017-2022)
5.2 Americas Neurological Disorder Drugs Sales by Type
5.3 Americas Neurological Disorder Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Neurological Disorder Drugs Sales by Region
6.1.1 APAC Neurological Disorder Drugs Sales by Region (2017-2022)
6.1.2 APAC Neurological Disorder Drugs Revenue by Region (2017-2022)
6.2 APAC Neurological Disorder Drugs Sales by Type
6.3 APAC Neurological Disorder Drugs Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Neurological Disorder Drugs by Country
7.1.1 Europe Neurological Disorder Drugs Sales by Country (2017-2022)
7.1.2 Europe Neurological Disorder Drugs Revenue by Country (2017-2022)
7.2 Europe Neurological Disorder Drugs Sales by Type
7.3 Europe Neurological Disorder Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Neurological Disorder Drugs by Country
8.1.1 Middle East & Africa Neurological Disorder Drugs Sales by Country (2017-2022)
8.1.2 Middle East & Africa Neurological Disorder Drugs Revenue by Country (2017-2022)
8.2 Middle East & Africa Neurological Disorder Drugs Sales by Type
8.3 Middle East & Africa Neurological Disorder Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Neurological Disorder Drugs
10.3 Manufacturing Process Analysis of Neurological Disorder Drugs
10.4 Industry Chain Structure of Neurological Disorder Drugs
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Neurological Disorder Drugs Distributors
11.3 Neurological Disorder Drugs Customer
12 World Forecast Review for Neurological Disorder Drugs by Geographic Region
12.1 Global Neurological Disorder Drugs Market Size Forecast by Region
12.1.1 Global Neurological Disorder Drugs Forecast by Region (2023-2028)
12.1.2 Global Neurological Disorder Drugs Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Neurological Disorder Drugs Forecast by Type
12.7 Global Neurological Disorder Drugs Forecast by Application
13 Key Players Analysis
13.1 Novartis
13.1.1 Novartis Company Information
13.1.2 Novartis Neurological Disorder Drugs Product Offered
13.1.3 Novartis Neurological Disorder Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Novartis Main Business Overview
13.1.5 Novartis Latest Developments
13.2 GlaxoSmithKline
13.2.1 GlaxoSmithKline Company Information
13.2.2 GlaxoSmithKline Neurological Disorder Drugs Product Offered
13.2.3 GlaxoSmithKline Neurological Disorder Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 GlaxoSmithKline Main Business Overview
13.2.5 GlaxoSmithKline Latest Developments
13.3 Merck & Co.
13.3.1 Merck & Co. Company Information
13.3.2 Merck & Co. Neurological Disorder Drugs Product Offered
13.3.3 Merck & Co. Neurological Disorder Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Merck & Co. Main Business Overview
13.3.5 Merck & Co. Latest Developments
13.4 Bayer
13.4.1 Bayer Company Information
13.4.2 Bayer Neurological Disorder Drugs Product Offered
13.4.3 Bayer Neurological Disorder Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Bayer Main Business Overview
13.4.5 Bayer Latest Developments
13.5 AstraZeneca
13.5.1 AstraZeneca Company Information
13.5.2 AstraZeneca Neurological Disorder Drugs Product Offered
13.5.3 AstraZeneca Neurological Disorder Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 AstraZeneca Main Business Overview
13.5.5 AstraZeneca Latest Developments
13.6 Boehringer Ingelheim
13.6.1 Boehringer Ingelheim Company Information
13.6.2 Boehringer Ingelheim Neurological Disorder Drugs Product Offered
13.6.3 Boehringer Ingelheim Neurological Disorder Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Boehringer Ingelheim Main Business Overview
13.6.5 Boehringer Ingelheim Latest Developments
13.7 Teva Pharmaceutical
13.7.1 Teva Pharmaceutical Company Information
13.7.2 Teva Pharmaceutical Neurological Disorder Drugs Product Offered
13.7.3 Teva Pharmaceutical Neurological Disorder Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Teva Pharmaceutical Main Business Overview
13.7.5 Teva Pharmaceutical Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Neurological Disorder Drugs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Neurological Disorder Drugs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Antipsychotic
Table 4. Major Players of Hypnotic & Sedative
Table 5. Major Players of Analgesics
Table 6. Major Players of Anticoagulants
Table 7. Major Players of Others
Table 8. Global Neurological Disorder Drugs Sales by Type (2017-2022) & (K Units)
Table 9. Global Neurological Disorder Drugs Sales Market Share by Type (2017-2022)
Table 10. Global Neurological Disorder Drugs Revenue by Type (2017-2022) & ($ million)
Table 11. Global Neurological Disorder Drugs Revenue Market Share by Type (2017-2022)
Table 12. Global Neurological Disorder Drugs Sale Price by Type (2017-2022) & (USD/Unit)
Table 13. Global Neurological Disorder Drugs Sales by Application (2017-2022) & (K Units)
Table 14. Global Neurological Disorder Drugs Sales Market Share by Application (2017-2022)
Table 15. Global Neurological Disorder Drugs Revenue by Application (2017-2022)
Table 16. Global Neurological Disorder Drugs Revenue Market Share by Application (2017-2022)
Table 17. Global Neurological Disorder Drugs Sale Price by Application (2017-2022) & (USD/Unit)
Table 18. Global Neurological Disorder Drugs Sales by Company (2020-2022) & (K Units)
Table 19. Global Neurological Disorder Drugs Sales Market Share by Company (2020-2022)
Table 20. Global Neurological Disorder Drugs Revenue by Company (2020-2022) ($ Millions)
Table 21. Global Neurological Disorder Drugs Revenue Market Share by Company (2020-2022)
Table 22. Global Neurological Disorder Drugs Sale Price by Company (2020-2022) & (USD/Unit)
Table 23. Key Manufacturers Neurological Disorder Drugs Producing Area Distribution and Sales Area
Table 24. Players Neurological Disorder Drugs Products Offered
Table 25. Neurological Disorder Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Neurological Disorder Drugs Sales by Geographic Region (2017-2022) & (K Units)
Table 29. Global Neurological Disorder Drugs Sales Market Share Geographic Region (2017-2022)
Table 30. Global Neurological Disorder Drugs Revenue by Geographic Region (2017-2022) & ($ millions)
Table 31. Global Neurological Disorder Drugs Revenue Market Share by Geographic Region (2017-2022)
Table 32. Global Neurological Disorder Drugs Sales by Country/Region (2017-2022) & (K Units)
Table 33. Global Neurological Disorder Drugs Sales Market Share by Country/Region (2017-2022)
Table 34. Global Neurological Disorder Drugs Revenue by Country/Region (2017-2022) & ($ millions)
Table 35. Global Neurological Disorder Drugs Revenue Market Share by Country/Region (2017-2022)
Table 36. Americas Neurological Disorder Drugs Sales by Country (2017-2022) & (K Units)
Table 37. Americas Neurological Disorder Drugs Sales Market Share by Country (2017-2022)
Table 38. Americas Neurological Disorder Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 39. Americas Neurological Disorder Drugs Revenue Market Share by Country (2017-2022)
Table 40. Americas Neurological Disorder Drugs Sales by Type (2017-2022) & (K Units)
Table 41. Americas Neurological Disorder Drugs Sales Market Share by Type (2017-2022)
Table 42. Americas Neurological Disorder Drugs Sales by Application (2017-2022) & (K Units)
Table 43. Americas Neurological Disorder Drugs Sales Market Share by Application (2017-2022)
Table 44. APAC Neurological Disorder Drugs Sales by Region (2017-2022) & (K Units)
Table 45. APAC Neurological Disorder Drugs Sales Market Share by Region (2017-2022)
Table 46. APAC Neurological Disorder Drugs Revenue by Region (2017-2022) & ($ Millions)
Table 47. APAC Neurological Disorder Drugs Revenue Market Share by Region (2017-2022)
Table 48. APAC Neurological Disorder Drugs Sales by Type (2017-2022) & (K Units)
Table 49. APAC Neurological Disorder Drugs Sales Market Share by Type (2017-2022)
Table 50. APAC Neurological Disorder Drugs Sales by Application (2017-2022) & (K Units)
Table 51. APAC Neurological Disorder Drugs Sales Market Share by Application (2017-2022)
Table 52. Europe Neurological Disorder Drugs Sales by Country (2017-2022) & (K Units)
Table 53. Europe Neurological Disorder Drugs Sales Market Share by Country (2017-2022)
Table 54. Europe Neurological Disorder Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 55. Europe Neurological Disorder Drugs Revenue Market Share by Country (2017-2022)
Table 56. Europe Neurological Disorder Drugs Sales by Type (2017-2022) & (K Units)
Table 57. Europe Neurological Disorder Drugs Sales Market Share by Type (2017-2022)
Table 58. Europe Neurological Disorder Drugs Sales by Application (2017-2022) & (K Units)
Table 59. Europe Neurological Disorder Drugs Sales Market Share by Application (2017-2022)
Table 60. Middle East & Africa Neurological Disorder Drugs Sales by Country (2017-2022) & (K Units)
Table 61. Middle East & Africa Neurological Disorder Drugs Sales Market Share by Country (2017-2022)
Table 62. Middle East & Africa Neurological Disorder Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 63. Middle East & Africa Neurological Disorder Drugs Revenue Market Share by Country (2017-2022)
Table 64. Middle East & Africa Neurological Disorder Drugs Sales by Type (2017-2022) & (K Units)
Table 65. Middle East & Africa Neurological Disorder Drugs Sales Market Share by Type (2017-2022)
Table 66. Middle East & Africa Neurological Disorder Drugs Sales by Application (2017-2022) & (K Units)
Table 67. Middle East & Africa Neurological Disorder Drugs Sales Market Share by Application (2017-2022)
Table 68. Key Market Drivers & Growth Opportunities of Neurological Disorder Drugs
Table 69. Key Market Challenges & Risks of Neurological Disorder Drugs
Table 70. Key Industry Trends of Neurological Disorder Drugs
Table 71. Neurological Disorder Drugs Raw Material
Table 72. Key Suppliers of Raw Materials
Table 73. Neurological Disorder Drugs Distributors List
Table 74. Neurological Disorder Drugs Customer List
Table 75. Global Neurological Disorder Drugs Sales Forecast by Region (2023-2028) & (K Units)
Table 76. Global Neurological Disorder Drugs Sales Market Forecast by Region
Table 77. Global Neurological Disorder Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
Table 78. Global Neurological Disorder Drugs Revenue Market Share Forecast by Region (2023-2028)
Table 79. Americas Neurological Disorder Drugs Sales Forecast by Country (2023-2028) & (K Units)
Table 80. Americas Neurological Disorder Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 81. APAC Neurological Disorder Drugs Sales Forecast by Region (2023-2028) & (K Units)
Table 82. APAC Neurological Disorder Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
Table 83. Europe Neurological Disorder Drugs Sales Forecast by Country (2023-2028) & (K Units)
Table 84. Europe Neurological Disorder Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Middle East & Africa Neurological Disorder Drugs Sales Forecast by Country (2023-2028) & (K Units)
Table 86. Middle East & Africa Neurological Disorder Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 87. Global Neurological Disorder Drugs Sales Forecast by Type (2023-2028) & (K Units)
Table 88. Global Neurological Disorder Drugs Sales Market Share Forecast by Type (2023-2028)
Table 89. Global Neurological Disorder Drugs Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 90. Global Neurological Disorder Drugs Revenue Market Share Forecast by Type (2023-2028)
Table 91. Global Neurological Disorder Drugs Sales Forecast by Application (2023-2028) & (K Units)
Table 92. Global Neurological Disorder Drugs Sales Market Share Forecast by Application (2023-2028)
Table 93. Global Neurological Disorder Drugs Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 94. Global Neurological Disorder Drugs Revenue Market Share Forecast by Application (2023-2028)
Table 95. Novartis Basic Information, Neurological Disorder Drugs Manufacturing Base, Sales Area and Its Competitors
Table 96. Novartis Neurological Disorder Drugs Product Offered
Table 97. Novartis Neurological Disorder Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 98. Novartis Main Business
Table 99. Novartis Latest Developments
Table 100. GlaxoSmithKline Basic Information, Neurological Disorder Drugs Manufacturing Base, Sales Area and Its Competitors
Table 101. GlaxoSmithKline Neurological Disorder Drugs Product Offered
Table 102. GlaxoSmithKline Neurological Disorder Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 103. GlaxoSmithKline Main Business
Table 104. GlaxoSmithKline Latest Developments
Table 105. Merck & Co. Basic Information, Neurological Disorder Drugs Manufacturing Base, Sales Area and Its Competitors
Table 106. Merck & Co. Neurological Disorder Drugs Product Offered
Table 107. Merck & Co. Neurological Disorder Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 108. Merck & Co. Main Business
Table 109. Merck & Co. Latest Developments
Table 110. Bayer Basic Information, Neurological Disorder Drugs Manufacturing Base, Sales Area and Its Competitors
Table 111. Bayer Neurological Disorder Drugs Product Offered
Table 112. Bayer Neurological Disorder Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 113. Bayer Main Business
Table 114. Bayer Latest Developments
Table 115. AstraZeneca Basic Information, Neurological Disorder Drugs Manufacturing Base, Sales Area and Its Competitors
Table 116. AstraZeneca Neurological Disorder Drugs Product Offered
Table 117. AstraZeneca Neurological Disorder Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 118. AstraZeneca Main Business
Table 119. AstraZeneca Latest Developments
Table 120. Boehringer Ingelheim Basic Information, Neurological Disorder Drugs Manufacturing Base, Sales Area and Its Competitors
Table 121. Boehringer Ingelheim Neurological Disorder Drugs Product Offered
Table 122. Boehringer Ingelheim Neurological Disorder Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 123. Boehringer Ingelheim Main Business
Table 124. Boehringer Ingelheim Latest Developments
Table 125. Teva Pharmaceutical Basic Information, Neurological Disorder Drugs Manufacturing Base, Sales Area and Its Competitors
Table 126. Teva Pharmaceutical Neurological Disorder Drugs Product Offered
Table 127. Teva Pharmaceutical Neurological Disorder Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 128. Teva Pharmaceutical Main Business
Table 129. Teva Pharmaceutical Latest Developments
List of Figures
Figure 1. Picture of Neurological Disorder Drugs
Figure 2. Neurological Disorder Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Neurological Disorder Drugs Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Neurological Disorder Drugs Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Neurological Disorder Drugs Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Antipsychotic
Figure 10. Product Picture of Hypnotic & Sedative
Figure 11. Product Picture of Analgesics
Figure 12. Product Picture of Anticoagulants
Figure 13. Product Picture of Others
Figure 14. Global Neurological Disorder Drugs Sales Market Share by Type in 2021
Figure 15. Global Neurological Disorder Drugs Revenue Market Share by Type (2017-2022)
Figure 16. Neurological Disorder Drugs Consumed in Hospital
Figure 17. Global Neurological Disorder Drugs Market: Hospital (2017-2022) & (K Units)
Figure 18. Neurological Disorder Drugs Consumed in Clinic
Figure 19. Global Neurological Disorder Drugs Market: Clinic (2017-2022) & (K Units)
Figure 20. Global Neurological Disorder Drugs Sales Market Share by Application (2017-2022)
Figure 21. Global Neurological Disorder Drugs Revenue Market Share by Application in 2021
Figure 22. Neurological Disorder Drugs Revenue Market by Company in 2021 ($ Million)
Figure 23. Global Neurological Disorder Drugs Revenue Market Share by Company in 2021
Figure 24. Global Neurological Disorder Drugs Sales Market Share by Geographic Region (2017-2022)
Figure 25. Global Neurological Disorder Drugs Revenue Market Share by Geographic Region in 2021
Figure 26. Global Neurological Disorder Drugs Sales Market Share by Region (2017-2022)
Figure 27. Global Neurological Disorder Drugs Revenue Market Share by Country/Region in 2021
Figure 28. Americas Neurological Disorder Drugs Sales 2017-2022 (K Units)
Figure 29. Americas Neurological Disorder Drugs Revenue 2017-2022 ($ Millions)
Figure 30. APAC Neurological Disorder Drugs Sales 2017-2022 (K Units)
Figure 31. APAC Neurological Disorder Drugs Revenue 2017-2022 ($ Millions)
Figure 32. Europe Neurological Disorder Drugs Sales 2017-2022 (K Units)
Figure 33. Europe Neurological Disorder Drugs Revenue 2017-2022 ($ Millions)
Figure 34. Middle East & Africa Neurological Disorder Drugs Sales 2017-2022 (K Units)
Figure 35. Middle East & Africa Neurological Disorder Drugs Revenue 2017-2022 ($ Millions)
Figure 36. Americas Neurological Disorder Drugs Sales Market Share by Country in 2021
Figure 37. Americas Neurological Disorder Drugs Revenue Market Share by Country in 2021
Figure 38. United States Neurological Disorder Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 39. Canada Neurological Disorder Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 40. Mexico Neurological Disorder Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 41. Brazil Neurological Disorder Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 42. APAC Neurological Disorder Drugs Sales Market Share by Region in 2021
Figure 43. APAC Neurological Disorder Drugs Revenue Market Share by Regions in 2021
Figure 44. China Neurological Disorder Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 45. Japan Neurological Disorder Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 46. South Korea Neurological Disorder Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 47. Southeast Asia Neurological Disorder Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 48. India Neurological Disorder Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 49. Australia Neurological Disorder Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 50. Europe Neurological Disorder Drugs Sales Market Share by Country in 2021
Figure 51. Europe Neurological Disorder Drugs Revenue Market Share by Country in 2021
Figure 52. Germany Neurological Disorder Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 53. France Neurological Disorder Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 54. UK Neurological Disorder Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 55. Italy Neurological Disorder Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 56. Russia Neurological Disorder Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 57. Middle East & Africa Neurological Disorder Drugs Sales Market Share by Country in 2021
Figure 58. Middle East & Africa Neurological Disorder Drugs Revenue Market Share by Country in 2021
Figure 59. Egypt Neurological Disorder Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 60. South Africa Neurological Disorder Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 61. Israel Neurological Disorder Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 62. Turkey Neurological Disorder Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 63. GCC Country Neurological Disorder Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 64. Manufacturing Cost Structure Analysis of Neurological Disorder Drugs in 2021
Figure 65. Manufacturing Process Analysis of Neurological Disorder Drugs
Figure 66. Industry Chain Structure of Neurological Disorder Drugs
Figure 67. Channels of Distribution
Figure 68. Distributors Profiles

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Loratadine Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 116

According to our LPI (LP Information) latest study, the global Loratadine market size was valued at US$ 138.8 million in 2023. With growing demand in downstream market, the Loratadine is forecast to a readjusted size of US$ 175.7 million by 2030 with a CAGR of 3.4% during review period. The research report highlights the growth potential of the global Loratadine market. Loratadine are expected to show stable growth in the future market. However, product differentiation, reducing costs, a......

Global Allergy Rhinitis Drugs Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 101

Market Overview of Global Allergy Rhinitis Drugs market: According to our latest research, the global Allergy Rhinitis Drugs market looks promising in the next 5 years. As of 2022, the global Allergy Rhinitis Drugs market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Allergic rhinitis, also known as hay fever, is a type of inflammation in the nose which occurs when the immune system overrea......

Global Loratadine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 07-Dec-2023        Price: US 3380 Onwards        Pages: 100

Market Overview of Global Loratadine market: According to our latest research, the global Loratadine market looks promising in the next 5 years. As of 2022, the global Loratadine market was estimated at USD 145.21 million, and it's anticipated to reach USD 210.61 million in 2028, with a CAGR of 6.39% during the forecast years. Loratadine is an antihistamine that reduces the effects of natural chemical histamine on the body. Histamine can produce symptoms of sneezing, itching,......

Global Desloratadine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 16-Nov-2023        Price: US 3380 Onwards        Pages: 109

Market Overview of Global Desloratadine market: According to our latest research, the global Desloratadine market looks promising in the next 5 years. As of 2022, the global Desloratadine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Desloratadine market, with a sys......

Global Clarityne Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 07-Nov-2023        Price: US 3380 Onwards        Pages: 103

Market Overview of Global Clarityne market: According to our latest research, the global Clarityne market looks promising in the next 5 years. As of 2022, the global Clarityne market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Clarityne market, with a systematical descri......

Global Allergic Rhinitis Drugs Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 07-Nov-2023        Price: US 3380 Onwards        Pages: 120

Market Overview of Global Allergic Rhinitis Drugs market: According to our latest research, the global Allergic Rhinitis Drugs market looks promising in the next 5 years. As of 2022, the global Allergic Rhinitis Drugs market was estimated at USD 3956.8 million, and it's anticipated to reach USD 5997.75 million in 2028, with a CAGR of 7.18% during the forecast years. Allergic rhinitis, or hay fever, is an allergic reaction to specific allergens. An allergen is an innocuous sub......

Global Desloratadine Market Insights, Forecast to 2029

Published: 29-Aug-2023        Price: US 4900 Onwards        Pages: 107

Belongs to the third generation histamine antagonist of tricyclic long - acting type. It is generally used to relieve the systemic and local symptoms of chronic idiopathic urticaria and perennial allergic rhinitis. The global Desloratadine market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period. The US & Canada market for Desloratadine is estimated to increase from $ million......

Global Neurological Disorder Drugs Market Insights, Forecast to 2029

Published: 14-Aug-2023        Price: US 4900 Onwards        Pages: 96

Several government initiatives across various countries to educate masses about the rise of various diseases and increasing healthcare sector producing new drugs are the prime reasons for growth of neurological disorder drugs market. European Parkinson's Disease Association, in Europe is actively supporting research and development by campaigning to raise awareness, and providing medication to patients is boosting the overall neurological disorder drugs market. This region is also witnessing ris......

Global Allergic Rhinitis Drugs Market Insights, Forecast to 2029

Published: 14-Aug-2023        Price: US 4900 Onwards        Pages: 125

In individuals with allergic rhinitis, the immune system overreacts and causes an allergic reaction when allergens such as pollen, mold, and dander come in contact with the immune system. The global Allergic Rhinitis Drugs market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period. The Americas accounted for the major shares of the allergy rhinitis drugs market during 2016. In ......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs